astragaloside a has been researched along with losartan potassium in 1 studies
Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) | Studies (losartan potassium) | Trials (losartan potassium) | Recent Studies (post-2010) (losartan potassium) |
---|---|---|---|---|---|
675 | 5 | 573 | 24,390 | 2,493 | 5,408 |
Protein | Taxonomy | astragaloside a (IC50) | losartan potassium (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 8.53 | |
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0049 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.0082 | |
Type-1 angiotensin II receptor | Cavia porcellus (domestic guinea pig) | 0.018 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, W; Han, Y; Xie, Y; Yan, S; Zhu, B | 1 |
1 other study(ies) available for astragaloside a and losartan potassium
Article | Year |
---|---|
Effect comparison of different formulation of Dang-Gui-Bu-Xu-Tang on myelosuppression mouse.
Topics: Animals; Bone Marrow Cells; Cell Cycle; Cells, Cultured; Coumaric Acids; Drugs, Chinese Herbal; Erythropoietin; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Immunocompromised Host; Leukocyte Count; Leukocytes; Male; Mice; Mice, Inbred BALB C; Saponins; Stromal Cells; Triterpenes; Whole-Body Irradiation | 2011 |